Edition:
United States

Medicrea International SA (ALMED.PA)

ALMED.PA on Paris Stock Exchange

4.17EUR
19 Oct 2017
Change (% chg)

€0.00 (+0.00%)
Prev Close
€4.17
Open
€4.17
Day's High
€4.17
Day's Low
€4.17
Volume
1
Avg. Vol
7,563
52-wk High
€6.37
52-wk Low
€3.28

Chart for

About

Medicrea International SA is a France-based company that specializes in the design and manufacture of medical devices. The Company's product range includes polyaxial implants, impacted lumbar cage, polyaxial spine system, cervical compressive staples, cervical IBD, Lumbar IBD, cervical cage and bone substitutes. The Company has... (more)

Overall

Beta: 0.96
Market Cap(Mil.): €53.15
Shares Outstanding(Mil.): 12.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.39 16.86
EPS (TTM): -- -- --
ROI: -- 13.79 11.22
ROE: -- 16.64 15.09

BRIEF-Medicrea International Q3 sales fall to ‍​6.4 million euros

* INABILITY TO DELIVER TO BRAZIL SINCE START OF 2017 TO RESULT IN SHORTFALL OF NEARLY EUR 2 MILLION IN SALES IN 2017‍​

Oct 12 2017

BRIEF-Medicrea International H1 operating loss before non-recurring charges widens to 3.6 million euros

* H1 NET LOSS EUR 5.1 MILLION VERSUS LOSS OF EUR 2.7 MILLION YEAR AGO

Oct 03 2017

BRIEF-Medicrea H1 revenue 14.7 million euros

* REPORTED ON TUESDAY H1 REVENUE OF EUR 14.7 MLN VS EUR 14.8 MLN YEAR AGO

Jul 12 2017

BRIEF-Medicrea International raises EUR 13 mln in capital increase

* PLACED ‍2,680,413​ NEW SHARES AT UNIT PRICE OF EUR 4.85, TOTALLING EUR 13 MILLION VERSUS EUR 10 MILLION PLANNED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 19 2017

BRIEF-Medicrea International gets FDA certification for spinal fixator Pass Tulip

* GETS FDA CERTIFICATION FOR SPINAL FIXATOR PASS TULIP Further company coverage: (Gdynia Newsroom)

Jun 16 2017

BRIEF-Medicrea International launches capital increase of about 10 million euros

* ANNOUNCES LAUNCH OF CAPITAL INCREASE OF ABOUT EUR 10 MILLION

Jun 16 2017

BRIEF-Medicrea international obtains FDA approval

* OBTAINS FDA APPROVAL FOR UNID HUB Source text: http://bit.ly/2rzwTtY Further company coverage: (Gdynia Newsroom)

Jun 16 2017

Earnings vs. Estimates